Abstract: A glass laminate structure is disclosed with a first and a second glass ply and a printed polymer ply interposed between the first and second glass plies, the printed polymer ply may be of PVB or PET having nanoparticle-containing ink adhered to at least a portion of a surface. Optionally there may be at least one further polymer ply which may be of PVB, PVA, COP or TPU. The nanoparticle-containing ink may contain electrically conductive nanoparticles, especially silver nanoparticle-containing ink. Also disclosed is a process for producing such a glass laminate structure.
Abstract: A glass laminate structure is disclosed with a first and a second glass ply and a printed polymer ply interposed between the first and second glass plies, the printed polymer ply may be of PVB or PET having nanoparticle-containing ink adhered to at least a portion of a surface. Optionally there may be at least one further polymer ply which may be of PVB, PVA, COP or TPU. The nanoparticle-containing ink may contain electrically conductive nanoparticles, especially silver nanoparticle-containing ink. Also disclosed is a process for producing such a glass laminate structure.
Abstract: A reagent selected from cholestenoic acid or an inhibitor of an enzyme in the cholestenoic acid biosynthetic or metabolic pathway for use in the treatment of neurodegenerative conditions. In particular, the reagent is a cholestenoic acid of a particular form, such as 3?,7?-dihydroxycholest-5-en-26-oic (3?,7?-diHCA), not previously associated with neural tissue or CSF. Pharmaceutical compositions, methods of treatment or prevention of neurodegenerative conditions as well as diagnostic methods and novel biomarkers form further aspects of the invention.
Type:
Grant
Filed:
February 26, 2014
Date of Patent:
March 12, 2019
Assignee:
SWANSEA UNIVERSITY
Inventors:
Ernest Arenas, William Griffiths, Yuqin Wang, Spyridon Theofilopoulos
Abstract: The invention relates to a kit and methods for quantitative detection of steroids in a sample. The kit comprises quantitative charge tags and an oxidizing agent.
Type:
Grant
Filed:
September 5, 2013
Date of Patent:
December 26, 2017
Assignee:
SWANSEA UNIVERSITY
Inventors:
William Griffiths, Yuqin Wang, Peter Crick, William Bentley
Abstract: A counter electrode generally shown as 1 is formed of a conductive substrate e.g. a glass substrate 10 on which is deposited doped oxide, e.g. a fluorine doped tin oxide 20. Overlaying the fluorine layer is a layer of a metal halide, e.g. platinum chloride 30 (5 Mm H2PtCl6(H2O6) in isoproply alcohol. Metal is deposited from the solution by treating with NIR. The tin oxide layer renders the glass electrically conductive, absorbs significantly in the NIR and allows for the subsequent heating of the Pt—Cl via a heat transfer process to make the counter electrode in a very efficient manner.
Type:
Application
Filed:
April 9, 2013
Publication date:
April 23, 2015
Applicant:
SWANSEA UNIVERSITY
Inventors:
Trystan Watson, David Worsley, Cecile Charbonneau
Abstract: A radiation beam, for example a therapeutic radiation beam such as an IMRT or VMAT X-ray beam is monitored using a Monolithic Active Pixel Sensor (MAPS) detector. Photons of the radiation beam can interact with the MAPS detector, and the radiation beam configuration can be estimated from the determined positions of the interactions. The detector is made sufficiently thin that it interacts only very weakly with the X-ray photons. For example, less than 1 in 103 of the X-ray photons might interact with the detector. Hence, the disturbance to the X-ray beam is negligible.
Type:
Application
Filed:
December 21, 2011
Publication date:
January 9, 2014
Applicants:
THE UNIVERSITY OF BRISTOL, UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST, SWANSEA UNIVERSITY
Inventors:
Jaap Velthuis, Richard Peter Hugtenburg, Catherine Hall, Ryan Page, Paul Stevens